Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Gyre Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | $0.03 | $0.03 | $0.03 |
| Q2 2025 | 1 | $0.02 | $0.02 | $0.02 |
| Q3 2025 | 1 | $0.03 | $0.03 | $0.03 |
| Q4 2025 | 1 | $0.04 | $0.04 | $0.04 |
Gyre Therapeutics, Inc. Earnings Date And Information
Gyre Therapeutics, Inc. last posted its earnings results on Monday, March 17th, 2025. The company reported $0.01 earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by $0.03. The company had revenue of 27.87 M for the quarter and had revenue of 105.76 M for the year. Gyre Therapeutics, Inc. has generated $0 earnings per share over the last year ($0.05 diluted earnings per share) and currently has a price-to-earnings ratio of 27.4. Gyre Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based on prior year's report dates.
Gyre Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/17/2025 | Q4 2024 | $0.04 | -$0.19 | -0.23 | $23.50 M | $27.87 M |
| 11/13/2024 | Q3 2024 | N/A | $0.06 | N/A | N/A | $25.49 M |
| 08/13/2024 | Q2 2024 | N/A | $0.04 | N/A | N/A | $25.23 M |
| 03/30/2024 | Q1 2024 | N/A | $0.09 | N/A | N/A | $27.17 M |
| 12/30/2023 | Q4 2023 | N/A | -$0.68 | N/A | $113.45 M | $29.98 M |
| 10/26/2023 | Q3 2023 | -$0.75 | -$0.68 | 0.07 | N/A | $30.74 M |
| 08/14/2023 | Q2 2023 | -$0.07 | $0.15 | 0.22 | N/A | $26.14 M |
| 05/15/2023 | Q1 2023 | -$1.05 | $0.14 | 1.19 | $400,000 | $24.44 M |
| 03/30/2023 | Q4 2022 | -$1.58 | -$0.06 | 1.52 | $400,000 | $-794,000 |
| 11/14/2022 | Q3 2022 | -$1.50 | -$0.05 | 1.45 | N/A | $29.17 M |
| 08/15/2022 | Q2 2022 | -$3.68 | $0.08 | 3.75 | $797,000 | $23.33 M |
| 05/09/2022 | Q1 2022 | N/A | $0.08 | N/A | $166,667 | $794,000 |
| 03/31/2022 | Q4 2021 | -$6.85 | -$0.65 | 6.2 | $675,000 | $2.44 M |
| 11/12/2021 | Q3 2021 | N/A | -$0.80 | N/A | $333,333 | $2.30 M |
| 08/05/2021 | Q2 2021 | N/A | -$0.64 | N/A | $1.07 M | $1.13 M |
| 05/06/2021 | Q1 2021 | N/A | -$0.79 | N/A | $50,000 | $1.47 M |
| 03/04/2021 | Q4 2020 | N/A | -$0.85 | N/A | $2.10 M | $2.03 M |
| 11/05/2020 | Q3 2020 | N/A | -$0.73 | N/A | $300,000 | $893,000 |
| 08/06/2020 | Q2 2020 | N/A | -$0.96 | N/A | $7.95 M | $1.66 M |
| 05/11/2020 | Q1 2020 | N/A | -$0.28 | N/A | $15.00 M | $16.37 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Gyre Therapeutics, Inc. Earnings: FAQ's
Gyre Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based offlast year's report dates.
The conference call for Gyre Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Gyre Therapeutics, Inc.'s latest earnings report can be read online.
Gyre Therapeutics, Inc. (:GYRE) has a recorded annual revenue of $105.76 M.
Gyre Therapeutics, Inc. (:GYRE) has a recorded net income of $12.09 M.Gyre Therapeutics, Inc. has generated $0.14 earnings per share over the last four quarters.
Gyre Therapeutics, Inc. (:GYRE) has a price-to-earnings ratio of 27.4 and price/earnings-to-growth ratio is 0.27.